Innate Pharma SA (IPHA)
1.68
+0.06
(+3.70%)
USD |
NASDAQ |
Apr 17, 14:44
Innate Pharma Research and Development Expense (Quarterly)
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Nicox SA | -- |
| DBV Technologies SA | 30.04M |
| Cellectis SA | 19.62M |
| Transgene SA | -- |
| Adocia SA | -- |